Health-system pharmacists' role in immunizing adults against pneumococcal disease and influenza

American Journal of Health-System Pharmacy

Volumn 56, Issue 17 SUPPL. 2, 1999, Pages

  Grabenstein, John D ^a   Bonasso, Josephine ^b  

^a US Army Medical Command   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Contraindications; Dosage; Dosage schedules; Health professions; Immunization; Influenza vaccines; Interventions; Patient information; Pharmaceutical care; Pharmacists, institutional; Pharmacy, institutional; Pneumococcal vaccines; Toxicity; Vaccines

Indexed keywords

ALKYLATING AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIGOUT AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTIMETABOLITE; ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; FIBRINOLYTIC AGENT; FOLIC ACID DERIVATIVE; GASTROINTESTINAL AGENT; HEMOSTATIC AGENT; HORMONE; IMMUNOLOGIC AGENT; INFLUENZA VACCINE; INTERFERON; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PNEUMOCOCCUS VACCINE; RADIOISOTOPE; SPASMOLYTIC AGENT; SULFONAMIDE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; VASODILATOR AGENT;

CLINICAL PHARMACY; CONFERENCE PAPER; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; GERIATRIC CARE; HEALTH CARE DELIVERY; HIGH RISK POPULATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INTRAMUSCULAR DRUG ADMINISTRATION; MEDICARE; PHARMACIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033199470     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.suppl_2.s3     Document Type: Conference Paper

References (51)

1. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1997; 46(RR-8):1-24.
2. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1999; 48 (RR):1-26.
3. Guide for adult immunization. 3rd ed. Philadelphia: American College of Physicians; 1994.
4. Ventura SJ, Peters KD, Martin JA et al. Births and deaths: United States, 1996. Mon Vital Stat Rep. 1997; 45(3, suppl 2).
5. Fedson DS. Adult immunization: summary of the National Vaccine Advisory Committee report. JAMA. 1994; 272:1133-7.
6. A call to action: improving influenza and pneumococcal immunization rates among high risk adults. Bethesda, MD: National Coalition for Adult Immunization; 1998.
7. Atkinson W, Furphy L, Humiston SG et al. Epidemiology and prevention of vaccine-preventable diseases. 5th ed. Atlanta: Centers for Disease Control and Prevention; 1999.
8. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices. MMWR. 1995; 44(RR-11):1-36.
9. Potter J, Stott DJ, Roberts MA et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997; 175:1-6.
10. Centers for Disease Control and Prevention. Immunizations for health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HIPAC). MMWR. 1997; 46(RR-18):1-42.
11. Bolyard EA, Tablan OC, Williams WW et al. Guidelines for infection control in health care personnel, 1998: Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1998; 19:407-63.
12. Centers for Disease Control and Prevention. General recommendations on immunization. MMWR. 1994; 43(RR-1):1-38.
13. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices: use of vaccines and immune globulins in persons with altered immunocompetence. MMWR. 1993; 42(RR-4):1-18.
14. Pau AK, McNicholl IR, Pursell KJ. Active immunization with HIV-infected patients. Pharmacotherapy. 1996; 16:163-70.
15. Glesby MJ, Hoover DR, Farzadegan H et al. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. J Infect Dis. 1996; 174:1332-6.
16. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47:533-43.
17. National Center for Health Services Research and Development. Report of the Task Force on the Pharmacist's Clinical Role. J Am Pharm Assoc. 1971; 11:482-5.
18. American Society of Hospital Pharmacists. ASHP technical assistance bulletin on the pharmacist's role in immunization. Am J Hosp Pharm. 1993; 50:501-5.
19. Grabenstein JD. Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes, and hospitals. Vaccine. 1998; 16:1705-10.
20. Grabenstein JD. Immunologic resources: annotated bibliography. Hosp Pharm. 1998; 33:323-4,327-30,332-3.
21. McEvoy GK, ed. AHFS drug information 99. Bethesda, MD: American Society of Health-System Pharmacists; 1999.
22. Grabenstein JD. Immunization delivery: a complete guide. St. Louis: Facts and Comparisons; 1997.
23. Grabenstein JD. ImmunoFacts: vaccines and immunologic drugs. St. Louis: Facts and Comparisons; 1999 Aug.
24. Peter G, ed. 1997 Red book: report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997.
25. Ranelli PL, Svarstad BL, Boh L. Factors affecting outcomes of medication-history interviewing by pharmacy students. Am J Hosp Pharm. 1989; 46:267-81.
26. Grabenstein JD. Immunizations: what's a health-system pharmacy to do? (Part 1). Hosp Pharm. 1998; 33:742,745-50,753.
27. Occupational Safety and Health Administration. OSHA requirements for hepatitis B vaccine. 29 C.F.R. 1910.1030(f). 1996 Feb 13.
28. Harrison JA, Mullen PD, Green LW. The health belief model: a decade later. Health Educ Q. 1992; 7:107-16.
29. Centers for Disease Control. Adult immunization: knowledge, attitudes, and practices - DeKalb and Fulton counties, Georgia, 1988. MMWR. 1988; 37:657-61.
30. Williams DM, Daughterly LM, Aycock DG et al. Effectiveness of improved targeting efforts for influenza immunization in an ambulatory-care setting. Hosp Pharm. 1987; 22:462-4.
31. Knoell KR, Leeds AL. Influenza vaccination program for elderly outpatients. Am J Hosp Pharm. 1991; 48:256-9.
32. Spruill WJ, Cooper JW, Taylor WJR. Pharmacist-coordinated pneumonia and influenza vaccination program. Am J Hosp Pharm. 1982; 39:1904-6.
33. Grabenstein JD, Smith LJ, Watson RR et al. Immunization outreach using individual need assessments of adults at an Army hospital. Public Health Rep. 1990; 105:311-6.
34. Vondracek TG, Pham TP, Huycke MM. A hospital-based pharmacy intervention program for pneumococcal vaccination. Arch Intern Med. 1998; 158:1543-7.
35. Casto DT, Chan J. Hospital-based immunization: a leadership role for hospital pharmacists. Am J Hosp Pharm. 1990; 47:521-2. Letter.
36. Landis S, Scarbrough ML. Using a vaccine manager to enhance in-hospital vaccine administration. J Fam Pract. 1995; 41:364-9.
37. 1998-2000 Comprehensive accreditation manual for hospitals. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 1999.
38. 1998-2000 Comprehensive accreditation manual for health care networks. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 1999.
39. Grabenstein JD. Immunizations: what's a health-system pharmacy to do? (Part 2). Hosp Pharm. 1998; 33:870-2,876-80.
40. 42 U.S.C. §300(aa)(11).
41. Grabenstein JD. Compensation for vaccine injury: balancing society's need and personal risk. Hosp Pharm. 1995; 30:831-2, 834-6.
42. Kapit RM, Grabenstein JD. Adverse events after immunization: reports and results. Hosp Pharm. 1995; 30:1031-2,1035-6,1038,1041.
43. Department of Health and Human Services. National Vaccine Injury Compensation Program: revisions and additions to the Vaccine Injury Table-II. Fed Regist. 1997; 62:7685-90.
44. Ringel M, ed. Adult immunization: protecting productivity. Bus Health. 1998; 16(Sep, suppl A):1-30.
45. Kodak employee influenza immunization reduced absences by 42%. FDC Rep. 1996; 58(Oct 14):T&G9-10.
46. Nichol KL, Lind A, Margolis KL et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 1995; 333:889-93.
47. Nichol KL, Margolis KL, Wuorenma J et al. The efficacy and cost-effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994; 331:778-84.
48. Mullooly JP, Bennett MD, Hornbrook MC et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med. 1994; 121:947-52.
49. Gable CB, Holzer SS, Engelhart L et al. Pneumococcal vaccine: efficacy and associated cost savings. JAMA. 1990; 264:2910-5.
50. Holzer SS, Gable CB, Friedman RB. Cost-effectiveness of pneumococcal vaccine: implications for managed care. J Res Pharm Econ. 1993; 5:79-95.
51. Sisk JE, Moskowitz AJ, Whang W et al. Cost effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA. 1997; 278:1333-9.